These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25039759)
1. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: reply. Sanford D; Lazo-Langner A J Thromb Haemost; 2014 Sep; 12(9):1574-5. PubMed ID: 25039759 [No Abstract] [Full Text] [Related]
2. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: comment. Tardy B; Chalayer E; Chapelle C; Mismetti P J Thromb Haemost; 2014 Sep; 12(9):1572-3. PubMed ID: 24976020 [No Abstract] [Full Text] [Related]
3. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials. Sanford D; Naidu A; Alizadeh N; Lazo-Langner A J Thromb Haemost; 2014 Jul; 12(7):1076-85. PubMed ID: 24796727 [TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin and survival in patients with malignant disease. Kakkar AK Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901 [No Abstract] [Full Text] [Related]
10. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices. Lee AY Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267 [No Abstract] [Full Text] [Related]
11. Does low-molecular-weight heparin influence cancer-related mortality? Meyer G Ann Oncol; 2007 Mar; 18(3):609-10. PubMed ID: 17322543 [No Abstract] [Full Text] [Related]
12. [Treatment guidelines for deep venous thrombosis and pulmonary embolus]. Harjola VP; Teittinen J Duodecim; 2001; 117(24):2603-10. PubMed ID: 12183822 [No Abstract] [Full Text] [Related]
13. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality? Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623 [No Abstract] [Full Text] [Related]
14. Vitamin K antagonists in anticoagulant therapy of patients with cancer. Pasierski T Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in cirrhosis. Villa E; De Maria N Liver Int; 2012 Jul; 32(6):878-9. PubMed ID: 22672641 [No Abstract] [Full Text] [Related]
16. Should patients with venous thromboembolism and cancer be treated differently? Smorenburg SM; Hutten BA; Prins MH Haemostasis; 1999 Dec; 29 Suppl S1():91-7. PubMed ID: 10629414 [TBL] [Abstract][Full Text] [Related]